143 related articles for article (PubMed ID: 37285147)
1. Venous Thromboembolism in Patients With Bullous Pemphigoid.
Schneeweiss MC; Merola JF; Wyss R; Silverberg JI; Mostaghimi A
JAMA Dermatol; 2023 Jul; 159(7):750-756. PubMed ID: 37285147
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases.
Schneeweiss MC; Kim SC; Wyss R; Jin Y; Chin K; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S
JAMA Dermatol; 2021 Jul; 157(7):805-816. PubMed ID: 34037662
[TBL] [Abstract][Full Text] [Related]
3. Association between bullous pemphigoid and risk of venous thromboembolism: A nationwide population-based cohort study.
Chen CL; Wu CY; Lyu YS; Chou YJ; Chang YT; Wu CY
J Dermatol; 2022 Aug; 49(8):753-761. PubMed ID: 35491650
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
[TBL] [Abstract][Full Text] [Related]
5. Risk of Incident Venous Thromboembolism Among Patients With Bullous Pemphigoid or Pemphigus Vulgaris: A Nationwide Cohort Study With Meta-Analysis.
Chen TL; Huang WT; Loh CH; Huang HK; Chi CC
J Am Heart Assoc; 2023 Sep; 12(17):e029740. PubMed ID: 37642024
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
Schneeweiss MC; Kirchgesner J; Wyss R; Jin Y; York C; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S; Glynn RJ
Br J Dermatol; 2022 Nov; 187(5):692-703. PubMed ID: 35718888
[TBL] [Abstract][Full Text] [Related]
7. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase-4 Inhibitor vs Second-generation Sulfonylurea.
Lee H; Chung HJ; Pawar A; Patorno E; Kim DH
JAMA Dermatol; 2020 Oct; 156(10):1107-1114. PubMed ID: 32697283
[TBL] [Abstract][Full Text] [Related]
9. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
[TBL] [Abstract][Full Text] [Related]
11. Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism.
Berry ASF; Finucane BM; Myers SM; Abril A; Kirchner HL; Ledbetter DH; Martin CL; Oetjens MT
JAMA; 2023 Jan; 329(3):235-243. PubMed ID: 36648468
[TBL] [Abstract][Full Text] [Related]
12. Risk of Venous Thromboembolism Among Adults With Atopic Dermatitis.
Chen TL; Huang WT; Loh CH; Huang HK; Chi CC
JAMA Dermatol; 2023 Jul; 159(7):720-727. PubMed ID: 37256633
[TBL] [Abstract][Full Text] [Related]
13. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
[TBL] [Abstract][Full Text] [Related]
14. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database.
Li J; Panucci G; Moeny D; Liu W; Maro JC; Toh S; Huang TY
JAMA Intern Med; 2018 Nov; 178(11):1482-1488. PubMed ID: 30285041
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden.
Balabanova Y; Farahmand B; Garmo H; Stattin P; Brobert G
BMJ Open; 2022 May; 12(5):e055485. PubMed ID: 35606159
[TBL] [Abstract][Full Text] [Related]
16. The Risk of Venous Thromboembolism in Patients with Gallstones.
Chen CH; Lin CL; Kao CH
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32340378
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk of venous thromboembolism in patients following appendectomy: a nationwide cohort study.
Chung WS; Chen Y; Chen W; Lin CL
J Thromb Thrombolysis; 2019 Oct; 48(3):483-490. PubMed ID: 31177485
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic Venous Thromboembolism After Achilles Tendon Rupture: A Nationwide Danish Cohort Study of 28,546 Patients With Achilles Tendon Rupture.
Pedersen MH; Wahlsten LR; Grønborg H; Gislason GH; Petersen MM; Bonde AN
Am J Sports Med; 2019 Nov; 47(13):3229-3237. PubMed ID: 31574237
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors.
Said JT; Liu M; Talia J; Singer SB; Semenov YR; Wei EX; Mostaghimi A; Nelson CA; Giobbie-Hurder A; LeBoeuf NR
JAMA Dermatol; 2022 May; 158(5):552-557. PubMed ID: 35416925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
